Careers
Discover our areas of expertise and contribute to innovation across 10+ industries.
Empower your formulations. Accelerate your innovation.
We are Safic-Alcan France
Safic-Alcan France is part of the Safic-Alcan Group, a global distributor of specialty chemical ingredients. We support manufacturers, formulators and R&D teams by connecting ingredients, expertise and local market knowledge.
What we do
Safic-Alcan distributes specialty chemical ingredients across a wide range of industries, including life sciences and performance materials. We act as a link between suppliers and local markets, ensuring reliable access to ingredients, technical information and application support.
How we support customers
Beyond ingredient distribution, Safic-Alcan provides local commercial and technical support, access to formulation expertise, regulatory assistance and supply chain reliability. Our teams work closely with customers to support development, sourcing and market needs.
Our local presence in France
Safic-Alcan France combines the strength of a global group with local teams, stock and expertise. This local presence enables proximity to customers, fast response times and market-specific support.
Accelerate your innovation with a trusted partner in specialty chemicals
Access global sourcing
through an international supplier network
Co-create your formula
with tailored support from our experts
Secure your supply chain
with streamlined and reliable global logistics
Innovate faster
with our integrated technical laboratories
Discover industry insights
See more insights
Article
Traditional gelatin-based softgels have long dominated the market as the preferred oral dosage form across the pharmaceutical and nutraceutical sectors, due to their ability to encapsulate oil-based ingredients and deliver precise doses in a sealed capsule shell. However, traditional gelatin systems are increasingly misaligned with modern consumer expectations and formulation needs, due to the animal-derived … <a href="https://www.safic-alcan.com/en-fr/industry-articles/veggie-softgels-benefits-applications-market-growth/">Continued</a>
Veggie Softgels: A Market-Driven Solution for Modern Nutraceutical and Pharmaceutical Delivery
Traditional gelatin-based softgels have long dominated the market as the preferred oral dosage form across the pharmaceutical and nutraceutical sectors, due to their ability to encapsulate oil-based ingredients and deliver precise doses in a sealed capsule shell. However, traditional gelatin systems are increasingly misaligned with modern consumer expectations and formulation needs, due to the animal-derived … <a href="https://www.safic-alcan.com/en-fr/industry-articles/veggie-softgels-benefits-applications-market-growth/">Continued</a>
Consumer Trends
Softgels capsules are a well-established oral dosage form, widely used in both pharmaceutical and nutraceutical applications due to their ability to encapsulate liquid and semi-solid formulations. Structurally, a softgel consists of a continuous shell surrounding a fill matrix, typically produced via rotary die encapsulation. Historically, the shell has been gelatin-based, providing the elasticity and film-forming … <a href="https://www.safic-alcan.com/en-fr/industry-articles/starch-based-veggie-softgels-gelatin-alternative/">Continued</a>
Advancing Soft Capsule Formulation: Veggie Softgel Technology as a Next-Generation Gelatin Replacement
Softgels capsules are a well-established oral dosage form, widely used in both pharmaceutical and nutraceutical applications due to their ability to encapsulate liquid and semi-solid formulations. Structurally, a softgel consists of a continuous shell surrounding a fill matrix, typically produced via rotary die encapsulation. Historically, the shell has been gelatin-based, providing the elasticity and film-forming … <a href="https://www.safic-alcan.com/en-fr/industry-articles/starch-based-veggie-softgels-gelatin-alternative/">Continued</a>
Supplier Focus
Since the Valsartan crisis in 2018, attention has shifted to an impurity that had long remained under the radar: nitrosamines. These potent genotoxic impurities, classified as probable human carcinogens, are not the result of isolated external contamination but a byproduct of specific chemical conditions during the manufacturing process. Following global recall and media coverage, new … <a href="https://www.safic-alcan.com/en-fr/industry-articles/nitrosamines-pharmaceutical-excipients-risk-management/">Continued</a>
